Balyasny Asset Management »

Adagio Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $342k 87k 3.94
2023-06-30 $14k 13k 1.05
2021-12-31 $1.9M 262k 7.26

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Adagio Therapeutics

Maverick Capital
M28 Capital Management
Alphabet
OrbiMed Advisors
683 Capital Management
Vanguard Group
Redmile Group
Millennium Management
Jacobs Levy Equity Management
Charles Schwab Investment Management
Citigroup
Acuitas Investments
Jane Street
Squarepoint Ops
Balyasny Asset Management

View all funds holding Adagio Therapeutics